Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

146.92 -1.43 (-0.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,992,767
Open 147.98
Bid (Size) 146.60 (10)
Ask (Size) 146.80 (2)
Prev. Close 148.35
Today's Range 146.18 - 149.66
52wk Range 115.03 - 217.25
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Check Out What Whales Are Doing With MRNA
 
Via Benzinga
2 Nasdaq 100 Stocks to Buy Hand Over Fist Right Now
Both have plenty of growth in the future, not to mention impressive histories. 
Via The Motley Fool

Performance

YTD
-17.92%
-17.92%
1 Month
+6.26%
+6.26%
3 Month
-18.45%
-18.45%
6 Month
+20.20%
+20.20%
1 Year
-15.11%
-15.11%

More News

Read More
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
Could CRISPR Therapeutics Become the Next Moderna?
Via The Motley Fool
3 Things About Moderna That Smart Investors Know
Via The Motley Fool
Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023
Via ACCESSWIRE
Why Generation Bio Shares Are Trading Higher Today
Via Benzinga
(MRNA) - Analyzing Moderna's Short Interest
Via Benzinga
Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
Via InvestorPlace
Apple Jumps Movie Production Bandwagon, Billionaire Jim Ratcliffe Bids For Manchester United, Elon Musk Seeks Funding For SpaceX From Middle-Eastern Fund: Today's Top Stories
Via Benzinga
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
Via ACCESSWIRE
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
From Generation Bio Co.; Moderna
Via Globe NewsWire
China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine
Via Benzinga
Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks
Via Benzinga
If You Invested $5,000 in Moderna in 2020, This Is How Much You Would Have Today
Via The Motley Fool
Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders
Via Investor's Business Daily
Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories
Via Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
Via Benzinga
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
Via Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Via Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via News Direct
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via TheNewswire.com
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.